Soleus Capital Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-102,067
Closed -$4.48M 97
2024
Q2
$4.48M Sell
102,067
-259,563
-72% -$11M 0.4% 64
2024
Q1
$15.9M Sell
361,630
-281,576
-44% -$12.4M 1.18% 26
2023
Q4
$30.5M Buy
643,206
+15,000
+2% +$631K 3.39% 9
2023
Q3
$27.9M Sell
628,206
-145,488
-19% -$6.76M 2.57% 9
2023
Q2
$36.9M Hold
773,694
4.11% 6
2023
Q1
$30.4M Buy
773,694
+28,690
+4% +$1.04M 3.15% 8
2022
Q4
$21.1M Buy
745,004
+60,314
+9% +$1.73M 3.02% 9
2022
Q3
$20.6M Buy
684,690
+63,925
+10% +$2.23M 2.8% 13
2022
Q2
$21.1M Buy
620,765
+190,714
+44% +$6.84M 3.29% 6
2022
Q1
$19.3M Sell
430,051
-19,979
-4% -$924K 2.49% 10
2021
Q4
$20.8M Sell
450,030
-649
-0.1% -$26.2K 2.08% 15
2021
Q3
$15.1M Sell
450,679
-46,500
-9% -$1.58M 2.36% 14
2021
Q2
$14.6M Buy
497,179
+15,109
+3% +$416K 2.25% 15
2021
Q1
$12.4M Buy
482,070
+178,072
+59% +$4.25M 2.24% 10
2020
Q4
$6.93M Buy
303,998
+105,259
+53% +$2.43M 0.91% 15
2020
Q3
$4.25M Sell
198,739
-13,697
-6% -$308K 2.25% 16
2020
Q2
$4.93M Sell
212,436
-22,374
-10% -$480K 2.81% 11
2020
Q1
$5.01M Buy
234,810
+94,058
+67% +$2.24M 5.83% 5
2019
Q4
$3.29M Buy
+140,752
New +$3.29M 3.17% 11

Other funds holding IRMD

Soleus Capital Management's IRMD Position: Q3 2024 in Review

Soleus Capital Management sold out of iRadimed (IRMD) in Q3 2024, closing a stake of 102,067 shares — an estimated $4.48M sold.

Soleus Capital Management first reported a position in IRMD in Q4 2019 and held it in 19 quarters. The position peaked at $36.9M in Q2 2023. 144 funds tracked by Wall St. Rank hold IRMD as of Q3 2024.

  • Soleus Capital Management reported no remaining iRadimed position as of Q3 2024 after selling out during the quarter.
  • Soleus Capital Management sold 102,067 iRadimed shares in Q3 2024, an estimated $4.48M.
  • Soleus Capital Management first reported a position in iRadimed in Q4 2019 and held it in 19 quarters.
  • Soleus Capital Management's iRadimed position peaked at $36.9M in Q2 2023.
  • 144 funds tracked by Wall St. Rank held iRadimed as of Q3 2024.

Based on Soleus Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.